483 QuVa Pharma Apr 2018

483 QuVa Pharma Apr 2018

Scott Ballard FDA$119.00 - Available Now

FDA investigators audited the QuVa Pharma - Temple, TX, United States facility and issued inspectional observations (via FDA 483) on 20 Apr 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Apr 2018
  • Location: Temple, United States
  • FEI: 3002468086
Add To Cart